| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 27.227 | 50.097 | 61.174 | 78.241 | 69.445 | 78.857 | 88.253 | 101.691 | 122.779 |
| Total Income - EUR | - | 27.240 | 50.097 | 61.175 | 78.242 | 70.480 | 78.859 | 88.255 | 101.693 | 122.782 |
| Total Expenses - EUR | - | 8.025 | 13.856 | 19.157 | 23.682 | 25.052 | 17.219 | 16.930 | 25.153 | 34.918 |
| Gross Profit/Loss - EUR | - | 19.215 | 36.242 | 42.018 | 54.560 | 45.428 | 61.641 | 71.325 | 76.540 | 87.864 |
| Net Profit/Loss - EUR | - | 18.943 | 35.741 | 41.406 | 53.778 | 44.772 | 60.868 | 70.459 | 75.645 | 84.254 |
| Employees | - | 2 | 2 | 3 | 3 | 3 | 2 | 1 | 2 | 2 |
Check the financial reports for the company - Adianez Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 464 |
| Current Assets | - | 21.596 | 36.520 | 78.151 | 56.073 | 79.876 | 88.900 | 72.153 | 81.593 | 88.373 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 2.400 | 3.940 | 4.898 | 7.188 | 1.125 | 3.963 | 3.929 | 31.869 | 10.903 |
| Cash | - | 19.196 | 32.580 | 73.252 | 48.885 | 78.751 | 84.937 | 68.223 | 49.723 | 77.470 |
| Shareholders Funds | - | 18.987 | 35.799 | 76.549 | 54.073 | 77.147 | 87.658 | 70.587 | 79.304 | 84.310 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.609 | 721 | 1.602 | 2.000 | 2.730 | 1.242 | 1.566 | 2.288 | 4.528 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Adianez Med S.r.l.